Cloud Banner

Pharmaceutical

Image

Global Gouty Arthritis Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • Aug 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Gouty Arthritis Market – Industry Trends and Forecast to 2029

Market Size in USD Billion

CAGR - 6.5% Diagram

Diagram Forecast Period 2021–2029
Diagram Market Size (Base Year) USD 3.00 Billion
Diagram Market Size (Forecast Year) USD 4.96 Billion
Diagram CAGR 6.5%

Global Gouty Arthritis Market, By Diagnosis (Joint Fluid Test, Blood Test, X-Ray Imaging, Ultrasound, Dual Energy CT Scan, Others), Treatment (NSAIDs, Pain Reliever, Corticosteroids, Xanthine Oxidase Inhibitors, Uricosurics, Others), Route of Administration (Oral, Parenteral, Topical, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) – Industry Trends and Forecast to 2029.

Gouty Arthritis Market

Gouty Arthritis Market Analysis and Size

The global gouty arthritis market is expected to witness significant growth during the forecast period. The growing acceptance of enhanced R&D on regeneration therapies, and rising incidence are the major drivers driving the gout therapeutics market. It typically affects men more than women and further damage to joints can be avoided by treatment. COVID-19 also had a major impact on the population and market growth.

Data Bridge Market Research analyses a growth rate in the global gouty arthritis market in the forecast period 2022-2029. The expected CAGR of global gouty arthritis market is tend to be around 6.50% in the mentioned forecast period. The market was valued at USD 3.0 billion in 2021, and it would grow upto USD 4.96 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Gouty arthritis is a common and complex form of inflammatory arthritis that affects anyone. It is characterized by severe pain in joint especially in big toe joint, redness, swelling and tenderness in joint. Gouty arthritis developed due to the accumulation of uric acid in joint which causes pain and inflammation. If left untreated, this condition may damage joints or kidneys as excessive accumulation of uric acid crystals would lead to kidney stone or failure. In majority of cases, it is witnessed with other metabolic diseases or conditions such as obesity, hypertension, and diabetes.

Gouty Arthritis Market Scope and Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

By Diagnosis (Joint Fluid Test, Blood Test, X-Ray Imaging, Ultrasound, Dual Energy CT Scan, Others), Treatment (NSAIDs, Pain Reliever, Corticosteroids, Xanthine Oxidase Inhibitors, Uricosurics, Others), Route of Administration (Oral, Parenteral, Topical, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Pfizer Inc. (U.S.), Abbvie Inc. (U.S.), Novartis AG (Switzerland), Amgen Inc. (U.S.), Boehringer Ingelheim International GmbH. (Germany), Samsung Bioepis. (South Korea), Merck & Co Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Teva Pharmaceuticals Industries Ltd. (Israel), AstraZeneca (U.K.), BioCryst Pharmaceuticals, Inc. (U.S.), JW Pharmaceutical (South Korea), Addex Therapeutics (Switzerland)

Market Opportunities

  • Increase in Elderly Population

Global Gouty Arthritis Market Dynamics

Drivers

  • High Prevalence of Chronic Diseases

According to a 2014 study published in the Journal of Rheumatology, about 75% of patients with gouty arthritis have high blood pressure. Therefore, patients suffering from chronic illness are at increased risk of developing gouty arthritis. The high prevalence of gouty arthritis is expected to drive the growth of the global gouty arthritis market.

  • Increased alcohol intake

Increased alcohol consumption is expected to drive the expansion of the gouty arthritis market during the forecast period as a result of the association between increased gout incidence and alcohol consumption and gout.

Opportunities

  • Increase in Elderly Population

Life expectancy is growing around the world, which has led to an increase in the aging population. This trend positively impacts the industry by increasing the incidence of the disease and creating per capita demand for its remedies.

Restraints/Challenges

  • Lack of skilled professionals

The lack of qualified personnel who are unable to perform the treatments could curb the growth of the global gouty arthritis market over a forecast period.

  • High Cost

The huge expenditure required for treatment process surely hamper the market growth.

This global gouty arthritis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global gouty arthritis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Gouty Arthritis Market Scope

The global gouty arthritis market is segmented on the basis of diagnosis, treatment, route of administration, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Diagnosis

  • Joint Fluid Test
  • Blood Test
  • X-Ray Imaging
  • Ultrasound
  • Dual Energy CT Scan
  • Others

Treatment

  • NSAIDs
  • Pain Reliever
  • Corticosteroids
  • Xanthine Oxidase Inhibitors
  • Uricosurics
  • Others

Route of Administration

  • Oral
  • Parenteral
  • Topical
  • Others

End-Users

  • Hospitals
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Others

Gouty Arthritis Market Regional Analysis/Insights

The global gouty arthritis market is analysed and market size insights and trends are provided by diagnosis, treatment, route of administration, end-user and distribution channel as referenced above.

The major countries covered in the global gouty arthritis market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the market due to increased prevalence of joint disease, and technological advancements in early diagnosis of the disease.

Asia-Pacific is expected to grow during forecast period due to increased joint replacement surgeries, increased awareness for joint disorders through advertisement & media and rapidly improving health care infrastructure in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Gouty Arthritis Market Share Analysis

The global gouty arthritis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global gouty arthritis market

Key players operating in the global gouty arthritis market include:

  • Pfizer Inc. (U.S.)
  • Abbvie Inc. (U.S.)
  • Novartis AG (Switzerland)
  • Amgen Inc. (U.S.)
  • Boehringer Ingelheim International GmbH. (Germany)
  • Samsung Bioepis. (South Korea)
  • Merck & Co Inc. (U.S.)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Teva Pharmaceuticals Industries Ltd. (Israel)
  • AstraZeneca PLC (U.K.)
  • BioCryst Pharmaceuticals, Inc. (U.S.)
  • JW Pharmaceutical Corporation (South Korea)
  • Addex Therapeutics (Switzerland)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The global gouty arthritis market is expected USD 4.96 billion by 2029.
The global gouty arthritis market is projected to grow at a CAGR of 6.50% during the forecast period of 2022-2029.
The major players operating in the Gouty Arthritis Market are Pfizer Inc. (U.S.), Abbvie Inc. (U.S.), Novartis AG (Switzerland), Amgen Inc. (U.S.), Boehringer Ingelheim International GmbH. (Germany), Samsung Bioepis. (South Korea), Merck & Co Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Teva Pharmaceuticals Industries Ltd. (Israel), AstraZeneca (U.K.), BioCryst Pharmaceuticals, Inc. (U.S.), JW Pharmaceutical (South Korea), Addex Therapeutics (Switzerland).
The major countries covered in the Gouty Arthritis Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials